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ABSTRACT 
 
Ceria nanoparticles with Rhodamine B groups covalently attached on their surface 
(RhB-CeNPs) were successfully prepared to simultaneously exhibit antioxidant activity 
and the ability to detect oxidant species. In order to use them for biomedical purposes, 
the nanoparticles were internalized in two human cell lines (HeLa and Hep3B), 
confirmed by confocal microscopy. In addition, their biocompatibility was assessed by 
performing proliferation, viability and apoptosis assays, in which they showed a 
remarkable lack of toxicity. Thereafter, the antioxidant activity of RhB-CeNPs against 
reactive oxygen species (ROS) in a model of oxidative stress was demonstrated in HeLa 
cells using the dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay. RhB-CeNPs 
exhibited higher cytosolic antioxidant activity than the well-established ceria 
nanoparticles. Surprisingly, the antioxidant capacity of RhB-CeNPs was evident when 
the ROS content of the cells increased notably (and was, therefore, harmful for those 
cells). Furthermore, the ability of RhB-CeNPs as ROS-content sensors was evaluated by 
measuring oxidative stress in HeLa cells using the intrinsic fluorescence of the 
Rhodamine B groups present on the nanoparticles. The results with respect to the 
detection and quantification of ROS were similar to those obtained with DCFH-DA, a 
typical method of quantifying intracellular ROS. Our results demonstrate the potential 
of RhB-CeNPs as remarkably biocompatibile theranostic agents with application in the 
field of oxidative stress. 
 
Keywords: Theranosis, ceria nanoparticles, oxidative stress, Rhodamine B, reactive 
oxygen species.  
  
INTRODUCTION 
 
Oxidative stress is one of the main factors of cellular aging and other cellular 
disorders.
1-4
 It is defined as an imbalance in the production of oxidant species and their 
effective removal by antioxidants and scavenger enzymes, and is one of the targets of 
therapies against diseases. In physiological conditions, a homeostatic balance exists 
between the formation of reactive oxygen species (ROS) and their elimination by 
endogenous antioxidant scavenging compounds and enzymes.
5 
The free radical 
hypothesis for tissue dysfunction postulates that ROS leads to a modification of lipids, 
proteins and nucleic acids, which, in turn, contributes to the etiology of different 
diseases.
6
 Importantly, low-to-moderate levels of ROS are physiologically normal and 
necessary for cell survival, while high levels are detrimental and can even cause cell 
death. For this reason, there is much current interest in developing new strategies to 
modulate ROS levels and, thus, control oxidative stress.
7-11
 With the aim of exploring in 
detail the role of ROS, several strategies have been tested in vivo and in vitro in order to 
evaluate the benefits of reducing oxidative stress in diseases such as cancer, diabetes, 
among others, with some beneficial effects being observed. The outcome of these 
studies has fuelled interest in developing new compounds and materials with 
antioxidant properties such as nanoparticles to control cellular oxidative stress.  
 
Nanoparticles are used in different fields, including advanced materials, chemistry, 
biology and medicine, and their synthesis and properties have been topics of continuous 
study in recent decades. The structure of nanomaterials allows the possibility of 
incorporating several guests into their cavities when they are porous, or of covalently 
anchoring several functional components to their surface due to the high percentage of 
external atoms. Furthermore, the composition and chemical properties of nanoparticles 
can be designed to make them inert or reactive versus substrates or the environment. 
These features make nanoparticles particularly suitable for use in biology and 
biomedicine, where nanoparticles have been tested as drug delivery systems, and 
antioxidant or imaging agents, among other potential uses.
12-17
 In spite of the range of 
opportunities offered by nanoparticles, which can exhibit multifunctionality, the most 
common application in biomedicine only exploits a single property of each one. 
However, recently there has been increased interest in applying nanomaterials as 
bifunctional or multifunctional materials. The multifunctionality of nanoparticles 
derives from their complementary reactivity, which is due to the simultaneous 
incorporation of different functional groups and molecules in their structure and 
moreover the intrinsic properties of the modified nanoparticle. In this way, some 
nanomaterials have been designed to combine optical and magnetic resonance imaging, 
therapy and optical imaging, radiotherapy and imaging, magnetism and imaging, among 
other possibilities.
18-22
 In this context, one of the emerging applications of nanoparticles 
is theranosis, which combines therapy and imaging. However, to our knowledge, no one 
has explored the possibility of using bifunctional nanoparticles as fluorescent biosensors 
of the concentration of ROS in cells and acting as antioxidants when the ROS 
concentration overcomes the damage threshold for cells. We believe it is possible to 
generate “intelligent” nanoparticulate materials in the field of theranostics to detect 
ROS content and to treat excess ROS, thus modulating antioxidant therapies in a 
harmless manner. This is the objective of the present work. 
 
Ceria nanoparticles (CeNPs) have been found to be biocompatible with several cellular 
types, exhibiting antioxidant activity due to their redox properties, which are 
attributable to oxygen vacancies on their surface and the presence of Ce
3+
 ions in their 
structure.
23,24
 In addition CeO2 NPs are stable in aqueous media at neutral pH values. 
The antioxidant activity of CeNPs can be enhanced by supporting metals in their 
structure, such as Au.
25
 The biocompatibility and redox properties of CeNPs have 
attracted interest from the field of biomedicine, and these nanoparticles have been 
proposed for some therapeutic applications. Accordingly, CeNPs have been tested in 
vitro and in vivo as quenchers of ROS in some types of cells, and as radiation 
protectors, cardioprotectors or reducers of endothelial inflammation, among other 
roles.
26-30
 
  
 
Rhodamine B (RhB) is a fluorophore with typical absorption and fluorescence bands 
centered approximately at 550 and 580 nm, respectively, and has been used for diverse 
purposes in chemistry, biology and medicine. The use of RhB derives mainly from its 
high fluorescence quantum yield and from the quenching of its fluorescence emission 
by energy transfer or electron transfer processes caused by the interaction of RhB with 
other compounds.
31-35
 In this sense, radical species or hydrogen peroxide (H2O2) can 
oxidize RhB, causing a decrease in fluorescence intensity that can correlate with the 
amount of oxidants, and is usually used to quantify the amount of oxidizing species.
36-38
 
Thus, RhB could be used as a sensor of the oxidant species present in a sample. In 
addition, some rhodamine dyes are currently used for biomedical purposes such as 
probes for mitochondria and the endoplasmic reticulum, where it appears to be 
relatively non-toxic.
39-41 
 
Due to the capacity of CeNPs as antioxidants and ROS scavengers, and the possibility 
of covalently attaching RhB to their surface to act as a sensor of oxidant species content, 
we have developed a novel theranostic nanoparticle to work both as a diagnostic agent 
of oxidant species content and a form of antioxidant therapy. 
 
RESULTS AND DISCUSSION 
 
In order to prepare a new class of nanomaterial with properties as both theranostic 
antioxidant and oxidant content sensor, RhB was covalently attached to CeNPs by 
modifying their surface. For this purpose, colloidal CeNPs were obtained by hydrolysis 
of Ce
4+
 salts in water at a controlled basic pH and purified by dialysis. The average 
nanoparticle size was determined from the width of the XRD peaks by applying the 
Scherrer equation, giving a value of 5.6 nm (Fig. S1, ESI†). Additionally, the XRD 
pattern of nanoparticles confirmed that the sample corresponded with CeO2, as the XRD 
coincided with that reported for CeO2. Additionally, the UV-Vis spectrum of CeNPs 
was recorded. No bands at wavelengths longer than 400 nm were observed for CeNPs 
(Fig. 1). Once CeNPs had been characterized, covalent funtionalization of their surface 
with amino groups was carried out by silylation of the surface OH groups with 3-
aminopropyltriethoxysilane in dry toluene. In this way, -aminopropyl-functionalized 
CeNPs (NH2-CeNPs) were obtained. This reaction takes place under neutral conditions 
and attaches the amino group through strong Ce-O- Si bonds.
 
These amino groups act as 
tethers that connect RhB to CeNPs. Subsequent reaction of these aminated NH2-CeNPs 
with RhB isothiocyanate forms a strong thiourea linkage between the organic 
fluorophore and the inorganic CeNPs, as depicted in Scheme 1.  The success of each 
synthesis step was assessed by chemical combustion analysis, diffuse reflectance UV-
Vis spectroscopy (Fig. 1) and FT-IR (Fig. 2). 
  
Scheme 1. Synthetic route followed to obtain NH2-CeNPs and RhB-CeNPs. 
 
 
 
 
 
Fig. 1 Diffuse reflectance UV-Vis absorption spectra (plotted as the Kubelka-Munk 
 function of the reflectivity, R) of CeNPs (a), NH2-CeNPs (b) and RhB-CeNPs (c). 
  
Fig. 2 FT-IR spectra of a) CeNPs, b) NH2-CeNPs, c) Rhodamine B isothiocyanate 
 and d) RhB-CeNPs. 
 
The presence of 3-aminopropyl groups anchored on the ceria surface was evident in the 
IR spectra of NH2-CeNPs; the two vibration bands characteristic of symmetric and 
asymmetric NH2 (3270 and 3230 cm
-1
) and CH2 stretching (2990 and 2950 cm
-1
) which 
were recorded as weak bands due to the low population of these groups. The loading of 
aminopropyl silyl groups on NH2-CeNPs was 4.1 mmol×g
-1
 based on the C and N 
content in this material, which was determined by combustion chemical analysis. 
Additionally, the XRD pattern of NH2-CeNPs with respect to CeNPs shows that surface 
functionalization occurred without a significant increase in the average particle of 
CeNPs that remained at roughly 5.6 nm (Fig. S1, ESI†). Subsequently, covalent 
attachment of RhB on NH2-CeNPs was carried out, producing a change in the colour of 
the NH2-CeNPs sample after functionalization that varied from light yellow to purple 
and was reflected in the diffuse reflectance spectra of the samples (Fig. 1). This change 
in the color upon surface functionalization of CeO2 by -aminopropyl groups could 
indicate the occurrence of some ligand to metal charge transfer complex between amino 
groups and of the silane and Ce
4+/3+
 ions having free coordination positions. As shown 
in Figure 1, the RhB-CeNPs sample exhibited an absorption band in the 500-600 nm 
region due to the anchored RhB dye. This RhB absorption band was somewhat broader 
than the optical spectrum of the Rhodamine thioisocyanate in solution. This broadness 
is a general phenomenon observed when organic dyes are supported on solid surfaces 
and is due to the formation of aggregates and/or the inhomogeneity of the surface in 
terms of polarity and presence of OH groups. Furthermore, as expected for the presence 
of RhB in RhB-CeNPs, this dye produced an intense emission. Figure 3 shows the 
excitation spectrum showing that RhB emission is observed upon excitation in a wide 
range of wavelengths going from 425 to 575 nm, coinciding with the absorption band 
(see Figure 1, plot c). No variation of the emission spectrum as a function of the 
excitation wavelength was observed and the emission maximum appeared at 600 nm. A 
suitable excitation wavelength was 510 nm.  
 
 
 
 
Fig. 3 Excitation (Exc, λexc= 510 nm) and fluorescence (Em, λem 600 nm) spectra 
recorded for RhB-CeNPs. 
 
Additionally, the anchoring of RhB was confirmed by FT-IR spectroscopy, which 
provided firm evidence of the success of the incorporation. Thus, upon introduction of 
RhB isothiocyanate (Fig. 2, spectrum d) the isocyanate peak of the RhB isocyanate 
precursor appearing at 2055 cm
-1
 disappeared, but the characteristic narrow peaks 
corresponding with the aromatic region of the xanthene core were clearly resolved in 
the RhB-CeNPs spectrum (Fig. 2, spectrum d). Combustion chemical analysis of S 
allowed us to determine the loading of RhB in the resulting RhB-CeNPs, which was 3.2 
mmol×g
-1
, corresponding with about 80 % of the NH2 groups present in RhB-CeNPs. 
Considering that the specific surface area of CeO2 is 180 m
2
×g
-1
, these loading results in 
average about 100 molecules per nm
2
. This average is clearly much too high and 
indicates that Scheme 1 is an over simplification and there must be under the 
preparation conditions a certain degree of self condensation of -aminopropyl 
triethoxysilanes as indicated in Scheme 2. These oligosiloxane condensates will be the 
species covalently attached to the surface of CeO2. 
 
Scheme 2. Condensation of w-aminopropyl triethoxysilane forming oligomers and 
resulting in a high RhB loading on CeO2 
.  
 To determine the particle size of RhB-CeNPs, a statistical analysis of RhB-CeNPs was 
performed by transmission electron microscopy (TEM), the size distribution revealing 
an average particle size of about 10 nm (Fig. 4).  
 
  
Fig. 4 Transmission electron microscopy recorded for RhB-CeNPs.  
 
In addition, RhB-CeNPs were submitted to dynamic light scattering study to determine 
their size distribution profile in suspension (Fig. S2, ESI†) and their zeta potential value 
(Fig. S3, ESI†). These data provide information about the surface modification of the 
CeNPs due to anchor RhB and the size and charge of the nanoparticles in aqueous 
solution, which is the medium used to biomedical purposes. Hydrodynamic size of 
RhB-CeNPs in water was about 54 nm, which was higher than the value determined by 
TEM (Fig. 4), but this may have reflected partial agglomeration of the nanoparticles 
and/or the presence of a cloud of water molecules solvating the RhB-CeNPs core. It 
should be noted that even though the surface of pristine nanoparticulate CeO2 is 
hydrophilic, upon modification with silanization and RhB dye the hydrophobicity of the 
particles has to increase. This hydrophobicity is responsible for the occurrence of some 
agglomeration in water to decrease the surface energy of the colloidal suspension. 
Regarding the stability of these nanoparticles, the zeta potential value at neutral pH was 
-25 mV, which is within the limit to be considered a persistent colloid. This zeta 
potential value seems to be the balance between the intrinsic negative value of CeNPs 
and the positive charges introduced by RhB.  
 Once the RhB-CeNPs were obtained, their antioxidant capacity was assessed using the 
ABTS radical scavenger test. This test consists in measuring the decrease of absorbance 
corresponding to ABTS
+
 (typically 410 nm) when a radical scavenger or antioxidant is 
added to the solution. The test is carried out by following basically the methodology 
described by Seeram, et al.
42
 Thus, initially ABTS
+
 needs to be obtained by passing a 
colorless 5 mM aqueous solution of ABTS through a filter containing MnO2. The 
resulting green solution of ABTS
+
 is centrifuged at 10000 rpm for 10 min at 20 ºC to 
remove any trace of MnO2. Freshly prepared supernatant is used to assess the 
antioxidant capacity of RhB-CeNPs by monitoring the decrease of the corresponding 
ABTS
+
 absorbance at 410 nm when different concentrations (0, 0.5, 1, 1.5, and 2 
mg/ml) of nanoparticles dispersed in PBS solution are added to the green solution. In 
order to avoid any possible interference in the UV-Vis ABTS
+
 spectrum due to the 
addition of RhB-CeNPs, the UV-Vis spectrum of a RhB-CeNPs control solution is 
measured simultaneously to subtract to the radical absorbance spectrum. As shown in 
Figure 5A, ABTS
+
 absorbance decreased gradually upon RhB-CeNPs addition. This 
fact confirms the antioxidant activity of the PBS solution of RhB-CeNPs and, therefore, 
the suitability of these nanoparticles as antioxidant therapeutic agents.   
 
 
  
Fig. 5 UV-Vis (A) and fluorescent (b, ex 350 nm) (B) spectra of ABTS radical cation 
after additioning different amounts of RhB-CeNPs. The insert shows the region where 
the decrease of the band is related with the radical scavenger or antioxidant assessment.  
 
On the other hand, RhB-CeNPs have RhB groups covalent anchored to the CeNPs 
surface that could be used as sensors to quantify the content of oxidant species. This 
assumption is based on the well-known capacity of RhB to react with oxidants such as 
radical species and H2O2, among others. This quenching can be followed by the 
disappearance of the fluorescence band at 580 nm, after excitation at 350 nm, 
characteristic of the RhB groups present in RhB-CeNPs. These fluorescence 
experiments were performed with the same samples used to establish the antioxidant 
capacity of these nanoparticles (Fig. 5B), after checking for the absence of fluorescence 
originating from ABTS
+ 
or ABTS. Additionally, the capacity of RhB-CeNPs as oxidant 
content sensors was confirmed by a similar experiment in which the RhB-CeNPs 
content was maintained constant and the concentration of ABTS
+
 was increased. For 
this purpose, the fluorescence spectra were recorded between 400-700 nm after exciting 
the sample at 350 nm. In this experiment, the characteristic fluorescence intensity of 
RhB present on RhB-CeNPs decreased progressively following the addition of ABTS
+ 
(Fig. 6A). The decrease of fluorescence intensity at different wavelengths (for example 
575, 600, 625 and 650 nm) followed a first order exponential plot versus the content of 
ABTS
•+
 as an oxidant compound model (Fig. 6B), and confirmed the ability of RhB-
CeNPs to quantify the amount of oxidant species. This capacity allows the 
determination of the concentration of ROS and H2O2, among others, in solution or in the 
cells, thus allowing their use as biosensors where the oxidant content may be observe by 
a decrease of the fluorescent band between 575-650 nm that correspond to RhB-CeNPs.  
 
 
 
Fig. 6 A) Fluorescent spectra of RhB-CeNPs in PBS solution recorded after the 
excitation at 350 nm and the addition of different aliquots of a 5 mM ABTS
+
 aqueous 
solution. B) Reduction of the fluorescence intensity of Rh-CeNPs solution at different 
wavelengths (575, 600, 625, 650 nm) after the addition of different aliquots of the 
ABTS
+
 aqueous solution. All the fitting are successfully adjusted to a first order 
exponential plot (575 nm: y = 3007.815 x e
(-x/6.258)
 + 200.502 , R
2
 = 0.9965; 600 nm: y = 
1185,720 x e
(-x/6.212)
 + 85.120, R
2
 = 0,9972; 625 nm: y = 260.635 x e
(-x/6.351)
 + 22.877, R
2
 
= 0.9957; 650 nm: y = 59.785 x e
(-x/6.281)
 + 5.668, R
2
 = 0.9961. 
 
Before studying the antioxidant behaviour of RhB-CeNPs in cells, their ability to 
become internalized by cells was confirmed by confocal laser scanning microscopy, by 
which we monitored the characteristic red fluorescence of the RhB group present in the 
RhB-CeNPs. Figure 7 shows a selected set of vertical Z confocal fluorescence images 
showing the intracellular location of RhB-CeNPs nanoparticles (red spots). The 
cytoplasmic distribution of RhB-CeNPs can be observed clearly in the enlarged image 
of a single cell shown in Figure 7 (lower panel). These results are compatible with 
previous reports that similar CeNPs samples can enter cells.
15 
 
 
 
Fig. 7 Analysis of the cellular up-take of RhB-CeNPs by confocal microscopy. HeLa 
cells were exposed to the nanoparticles for 3h and live imaging was performed 
thereafter. Representative images of z-stack (a to d or a to f). A) Images show the 
overlapping of light microscopy and fluorescence microcopy (the cytoplasm was 
stained with N-Acridine orange (NAO) fluorescing in green). B) Single cell images 
show the fluorescent green signal coming from the nucleic acid stain SYTO80 whereas 
RhB-CeNPs autofluoresce in red. 
 
Once RhB-CeNPs had been confirmed as both antioxidant agents and oxidant content 
sensors in aqueous solution and were shown to be internalized inside cells, their toxicity 
and capacity as sensors and antioxidants were evaluated in human cell culture models. 
Cytotoxicity is a major issue in the applicability of nanoparticles in biomedicine. For 
this reason, several experiments were performed to assess the effect of RhB-CeNPs on 
the viability, survival and proliferation of cultured cells. Two human cell lines (HeLa 
and Hep3B) were used in order to avoid cell-type specificity. The results of the cell 
viability assessment (MTT assay) showed that the addition of CeNPs to the culture 
medium (incubation for 3 h followed by 21 h recovery) had no effect on the viability of 
either HeLa or Hep3B cells. RhB-CeNPs significantly diminished the viability of HeLa 
cells (approximately 50%), whereas only a slight and non-significant decrease was 
detected in Hep3B cells (Fig. S4, ESI†). Cell survival and exponential proliferation was 
studied further in both cell lines over a period of 3 days (fluorescence microscopy). 
RhB-CeNPs did not have a significant effect on cell survival or cell proliferation rate in 
either of the two cell lines, and results were similar to those observed for the control 
(untreated cells) at all the time points analyzed (24, 48 and 72 h). This suggests that the 
effect produced on cell viability in HeLa cells under treatment with RhB-CeNPs did not 
have major consequences on the survival of these fast proliferating cells over a longer 
period of time. 
 
In order to confirm and expand the findings of the proliferation/survival experiments 
showing the lack of a cytotoxic effect, we determined the capacity of RhB-CeNPs to 
induce apoptosis in HeLa and Hep3B cells (incubation for 3h followed by 21h 
recovery). The widely used kinase inhibitor staurosporine was employed as a positive 
control for apoptotic induction. Several typical markers of apoptotic cell death were 
analyzed by fluorescence microscopy. An increase in mean Hoechst 44432 fluorescence 
(nuclear staining), indicative of increased chromatin condensation, which is a hallmark 
of apoptosis, was detected in both cell types after 24 h-treatment with staurosporine. Of 
note, neither CeNPs nor RhB-CeNPs provoked any alteration in this parameter (Fig. 
S5A, ESI†). Similarly, a lack of apoptotic induction was observed when a Bivariate 
Annexin V/PI analysis was performed. Four distinct subpopulations of cells were 
evaluated: vital (Annexin V
-
/PI
-
), early apoptotic or classically apoptotic (Annexin 
V
+
/PI
-
), late apoptotic/necrotic (Annexin V
+
/PI
+
), and damaged or classically necrotic 
(Annexin V
-
/PI
+
). The results are shown in Figure S5B (See ESI†) (bar charts 
representing summary of the mean fluorescence data for both fluorochromes in both cell 
types). Figure S5C (See ESI†) depicts a representative cytogram of Hep3B cells in 
which the positive control (staurosporine 1 M) triggered typical apoptosis in 45 % of 
the cells compared to the presence of only 1.2 % apoptotic cells in the negative control. 
CeNPs did not provoke a significant increase in the apoptotic subcellular population 
(3.77 % apoptotic cells in the presence of CeNPs). Moreover, there was a lack of a 
significant increase in the number of necrotic cells. This double staining experiment 
could not be performed for RhB-CeNPs due to the intense red fluorescence of RhB that 
interferes with the PI emission of the assay. To sum up, the obtained evidence indicates 
that short-term exposure to the nanoparticles under study does not trigger cell death in 
cultured human cells. 
 
The oxidant content of the cells was measured by means of the DCFH-DA assay, which 
is one of the most usual methods of detecting intracellular ROS for oxidative stress 
assessment.
7,9,10
 The results obtained when we tested the activity of CeNPs and RhB-
CeNPs against oxidative stress in HeLa cells are shown in Figure 8. Both CeNPs and 
RhB-CeNPs reduced the oxidant content of HeLa cells, but only at high rotenone 
concentrations (125 M, P<0.05; 150 M, P<0.01), while the latter were more active in 
reducing cellular oxidative stress. There are numerous reports describing the anti-ROS 
activity of CeNPs, so it is expected that, when RhB are anchored to the surface of 
CeNPs, the antioxidant activity of these nanoparticles increases significantly, probably 
due to the tendency of the RhB group to undergo oxidation, as previously 
discussed.
15,26,28 
 
 
 
Fig. 8 Effect of CeNPs (20 μg/mL), RhB-CeNPs (20 μg/mL) on Rotenone-induced ROS 
production. Bar charts showing DCFH fluorescence intensity in Hela cells versus 
different Rotenone concentration. Data (mean ± SEM, n=3) were analyzed by 1 way 
ANOVA test, significance vs control (untreated cells) * p<0.05 and ** p<0.01. 
 
On the other hand, the ability of RhB-CeNPs as ROS content sensors was studied by 
recording the fluorescence emission of cells which had been previously incubated with 
the same amount of RhB-CeNPs and after the addition of different rotenone amounts at 
575, 600, 625 and 650 nm. As shown in Figure 9, the decrease in the fluorescence 
intensity at different wavelengths (575, 600, 625 and 650 nm) owing to RhB-CeNPs 
was higher when the oxidative stress was increased by higher rotenone concentrations. 
 
 
 
Fig. 9 Effect of applying different concentration of Rotenone on the fluorescence 
intensity of RhB-CeNPs (20 μg/mL) at different wavelengths (575, 600, 625 and 650 
nm) in HeLa cells. Data (mean ± SEM, n=8) were analyzed by 1 way ANOVA test, 
significance vs control (untreated cells) * p<0.05 and ** p<0.01.  
 
The data correlated with the results of the DCFH-DA probe assay, which is the most 
usual method of checking the ROS content of cells. These fluorescence intensity data 
confirm the capacity of RhB-CeNPs as a theranostic nanomaterial that acts 
simultaneously as a ROS quencher and biosensor. In addition, RhB-CeNPs as sensors 
have the additional advantage of being able to report at different wavelengths without 
losing sensor capacity for ROS species. 
 
 
 
EXPERIMENTAL SECTION 
 
Solvents and reagents 
 
Unless otherwise indicated, the solvents and reagents employed in both the preparation 
of materials and in cell culture were purchased from Sigma-Aldrich (Madrid, Spain), 
Scharlab (Sentmenat, Spain), Life Technologies (Madrid, Spain), or GIBCO 
(Invitrogen, Eugene, OR) and were used in the form in which they were supplied. The 
Annexin-V-FLUOS staining kit was from Roche Diagnostics (Sant Cugat del Vallés, 
Spain). Gases were supplied by Air-Liquide (Valencia, Spain). 96- and 48-well plates 
were purchased from Falcon BD (Madrid, Spain) and the Nunc 8-well coverslip bottom 
chamber slides for confocal microscopy were supplied by Thermo Scientific (Madrid, 
Spain). 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) was purchased from Life 
Technologies (Madrid, Spain).  
 
Instrumentation 
 
Synthesis and characterization of nanoparticles 
 
Combustion chemical analysis (C, H, N, and S) were performed in a FISONS CHNOS 
analyzer. UV-Vis spectra were recorded in transmission mode on a Shimadzu UV-Vis 
spectrophotometer using quartz cuvettes of 1 cm path length. Fluorescence 
measurements were performed with a Synergy Mx plate reader fluorimeter (BioTek 
Instruments, Winooski, VT) or on a JASCO FP-8500 spectrofluorometer (Mary's Court, 
Easton, MD) provided with a monochromator of variable wavelength in the range of 
200-900 nm. FT-IR spectra were recorded on a Nicolet 710 FT-IR spectrophotometer 
using KBr disks or self-supported wafers (10 mg) compressed to 2 Ton cm
2
 for 2 min. 
Transmission electron microscopy (TEM) images were acquired by a Philips CM300 
FEG system with an operating voltage of 100 kV by placing microdrops of CeNPs 
suspensions directly onto a copper grid coated with carbon film (200 mesh). Powder 
XRD was recorded with a Philips X’Pert diffractometer using the Cu K radiation at a 
scan rate of 2
o
 min
-1
. Dynamic Light Scattering used to determine the size and zeta 
potential of colloidal aqueous solutions of nanoparticles was performed on a Zetasizer 
Nano ZS (Malvern Instrument, Malvern, UK). 5 mg of nanoparticles were suspended in 
100 mL for measurements, which were carried out in an automatic mode. The values of 
size and zeta potential are the average of 30 runs. The centrifuge used was a Hettich-
Zentrifugen one (Tuttlingen, Germany). 
 
Cell culture 
 
The incubator used for cell culture was an IGO 150 (Jouan, Saint-Herblain, France). 
Confocal images were acquired using a Leica TCS-SP2 confocal laser scanning unit 
equipped with argon and Helium-Neon laser beams and attached to a Leica DM1RB 
inverted microscope.  In the apoptosis studies, fluorescence was quantified using the 
IX81 Olympus fluorescence microscope coupled with static cytometry software 
“ScanR” version 2.03.2 Olympus (Hamburg, Germany) Fluorescence measurements for 
ROS quantification were performed with a Synergy Mx plate reader fluorimeter 
(BioTek Instruments, Winooski, VT). Coloriemtric analyses (MTT assay) were 
performed using a multiscan Thermo Labsystems plate-reader spectrophotometer 
(Thermoscientific, Rockford, IL). 
Synthesis of Rhodamine B-functionalized CeNPs (RhB-CeNPs) 
 
Synthesis of CeNPs 
 
CeNPs were prepared by hydrolysis of Ce(NO3)4 at pH=9 using (NH4)OH as reported.
15
 
In brief, an ammonia aqueous solution (1.12 L, 0.8 M) was added under constant 
stirring and at room temperature over 375 mL of Ce(NO3)4 (0.8 M), and the dispersion 
was heated in a poly(ethyleneterephthalate) vessel at 100 
o
C for 24 h. The resulting 
yellow solid was filtered and dried under vacuum overnight. The success of the 
synthesis was determined by XRD, UV-Vis and FT-IR. The surface area of CeNPs 
measured by isothermal N2 adsorption at -198 ºC using a Micromeritics ASAP2000 and 
applying the Brunaer-Emmett-Teller (BET) algorithm was 180 m
2
 x g
-1
. 
 
Preparation of 3-aminopropyl-functionalized CeNPs (NH2-CeNPs) 
 
Silylation of CeNPs was carried out by stirring a suspension of 1 g of dried CeNPs 
sample for 3 h under atmospheric pressure) in 15 mL toluene containing 0.5 mL of 3-
(aminopropyl)triethoxysilane at reflux temperature for 2 h. Afterwards, the mixture was 
allowed to cool at room temperature and NH2-CeNPs was decanted and washed with 
fresh toluene aliquots (3 × 2 mL) and allowed to dry, again at room temperature. The 
percentage of aminopropyl groups was determined by combustion elemental analysis 
and the success of the functionalization was further assessed by UV-Vis, XRD and FT-
IR. 
 
 
Preparation of Rhodamine B-functionalized CeNPs (RhB-CeNPS) 
 
0.5 g of NH2-CeNPs was suspended in 15 mL of CH2Cl2, to which 0.100 g of 
Rhodamine B thioisocyanate was added. The suspension was stirred magnetically at 
reflux temperature for 4 h. After this time, the solid was collected and washed with 
fresh CH2Cl2 until it became colorless (7×20 mL). The resulting RhB-CeNPs was dried 
at room temperature under reduced pressure. Following this, nanoparticles were 
characterized by combustion elemental analysis, TEM, FT-IR, dynamic light scattering 
and UV-Vis/Fluorescence spectroscopy. 
 
Assessment of RhB-CeNPs as antioxidant and radical sensor agents.  
 
2,2-Azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS) radical cation
 
solution 
for radical scavenger-antioxidant assays 
 
ABTS radical cation (ABTS
+
) was prepared following the methodology described by 
Seeram, et al with minor changes.
42
 In short, a 5 mM water solution of ABTS was 
passed through a Whatman filter containing MnO2. The resulting green solution was 
centrifuged at 5000 rpm for 10 min at 20 ºC and the supernatant solution was used 
inmediately for radical scavenger-antioxidant experiments. 
 
Assessment of the antioxidant behaviour of RhB-CeNPs 
 
We prepared 50 l of freshly prepared ABTS+ solution and 200 L of several RhB-
CeNPs solutions at different concentrations (0, 0.5, 1, 1.5, and 2 mg/mL) in phosphate 
buffered saline solution (PBS). These mixtures were poured into a 96-well plate and 
stirred for 10 min. After this time, absorption and fluorescence spectra (exc 350 nm / 
em 400-700 nm) were recorded. This experiment was performed in triplicate using 
three replicates in each case. 
 
Assessment of RhB-CeNPs as antioxidant sensors 
 
Aliquots of 1 L of freshly prepared ABTS+ solution were added consecutively to a 0.1 
mg/mL solution of RhB-CeNPs in PBS, until a total of 15 L,and, from that point, 
aliquots of 5 L were added up until a total of 30 L. Each mixture was stirred in the 
dark at room temperature for 30 min before measuring fluorescence, which was done 
after sample excitation at 350 nm. Fluorescence was recorded between 400-700 nm.  
 
Cell Culture 
 
Experiments were performed with the human hepatoma Hep3B (ATCC HB-8064) and 
the human cervical carcinoma HeLa (ATCC CCL-2) cell lines. Reagents employed in 
cell culture were purchased from GIBCO. Hep3B cells were cultured in minimum 
essential medium (MEM) supplemented with 1 mM nonessential amino acids, whereas 
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with a high 
glucose concentration (4.5 mg/mL). Both culture media were supplemented with 10 % 
heat-inactivated fetal bovine serum (FBS) and the antibiotics penicillin 50 U/mL and 
streptomycin 50 g/mL. Cells were maintained in an incubator at 37 °C in a humidified 
atmosphere of 5% CO2/95% air. 
 
Confocal laser scanning microscopy images 
 
HeLa cells were seeded at 10000 cells/well in Nunc 8-well coverslip bottom chamber 
slides. Treatment with RhB-CeNPs was performed over 3 h, after which cells were  
incubated for a further 30 min with 5 M Syto80, a green fluorescent marker which 
preferentially stains nucleic acids, or 2.5 M 10N nonyl-acridine orange (NAO) in order 
to stain the cytoplasm. Subsequently, the cell culture was washed twice with Hank’s 
Balanced Salt Solution (HBSS) and immediately submitted to image acquisition using 
confocal microscopy. The excitation wavelengths for the fluorochromes were 488 nm 
for Syto 80 and 543 nm for RhB-CeNPs, and the emission apertures for fluorescence 
detection were 510–540 nm for Syto80 and 575–650 nm for RhB-CeNPs. The Z-section 
series were obtained by progressive increments of 1.0 ± 0.2 m. 
 
Proliferation and Viability  
 
Cells were seeded in 48-well plates one day before the experiment at 15000 and 5000 
cells/well for Hep3B and HeLa, respectively. Incubation in the presence of RhB-CeNPs 
(at 20 g/mL) took place for 3h, after which the medium was refreshed and cells were 
allowed to proliferate exponentially for 3 days. Cell count was performed at 24, 48, and 
72 h by means of fluorescence microscopy coupled with static cytometry. For this, 1 
M of the chromatin-staining dye Hoechst 33342 was added for the last 30 min of  
treatment and the cells were washed with HBSS. All treatments were performed in 
duplicate, and 25 images per well were recorded with a IX81 Olympus fluorescence 
microscope coupled with static cytometry software “ScanR” version 2.03.2. 
 
In addition, the 3-[4,5-dimethylthiazol-2-yl]-2,5-diprenyl tetrazolium bromide (MTT) 
assay was performed. MTT is a colorimetric assay based on the ability of cells to reduce 
a soluble yellow tetrazolium salt to blue formazan crystals.[9]  This reduction takes 
place only when mitochondrial reductase enzymes are active and is, thus, a marker of 
cell viability related to mitochondrial function. For these experiments, cells were seeded 
in 96-well plates at 20000 and 50000 cells/well for Hep3B and HeLa, respectively. 
Incubation with RhB-CeNPs (at 20 g/mL) was performed over 3 h, after which the 
medium was refreshed and cells were further cultured for a total of a 24 h. MTT reagent 
(Roche Diagnostics, Mannheim, Germany) was added (20 L/well) for the last 4 h of 
the treatment. Cells were solubilized with dimethyl sulfoxide (DMSO) (100 L/well, 5 
min, 37 °C), and absorbance was detected using a Thermo Labsystems Multiscan plate-
reader spectrophotometer. Results were obtained by subtracting the intensity of the 
signal at 690 nm from the 570 nm absorbance, as indicated in the instructions provided 
with the kit. 
 
Apoptosis  
 
Induction of apoptosis was studied by Bivariate Annexin V/PI analysis for which HeLa 
and Hep3B cells were seeded in duplicate in 48-well plates at 20000 and 30000 
cells/well respectively. Staurosporine (STS), a widely used protein kinase inhibitor, was 
employed as a positive proapoptotic control using 0.1 M and 1 M for HeLa and 
Hep3B, respectively.[9] Incubation with RhB-CeNPs (at 20 g/mL) was performed 
over 3 h, after which the medium was refreshed and cells were cultured for a further 
period of 24 h. The medium was then replaced with HBSS containing 1 M of Hoechst 
33342 to stain nuclei and 0.9 L Annexin V-fluorescein in order to detect 
phosphatidylserine exteriorization, and cells were incubated in the dark for 20 min at 37 
°C. Thereafter, 0.3 L of the chromatin detecting dye propidium iodide (PI) was added 
(5 min) to label dead or damaged cells. Annexin V and PI solutions were purchased in 
the form of the Annexin-V-FLUOS staining kit. Analysis was performed of 25 
images/well recorded with a IX81 Olympus fluorescence microscope coupled with 
static cytometry software “ScanR” version 2.03.2. 
 
ROS production and assessment of RhB-CeNPs as antioxidant agents and sensors 
 
To assess ROS content, the day before the experiment HeLa cells were seeded in 96-
well plates at 20,000 cells/well in Dulbecco’s Modified Eagle’s Medium (DMEM) 
containing 10 % heat inactivated fetal bovine serum, 2 mM L-glutamine, 1mM sodium 
pyruvate, 50 μg/ml penicillin and 50 μg/ml streptomycin. 
Culture medium was removed from cells and fresh medium with or without 20 μg/ml 
RhB-CeNPs and CeNPs were added. Cells were incubated for 3h at 37 ºC under gentle 
agitation. The medium was then replaced with preheated PBS containing 2.5 μM 2,7-
dichlorodihydrofluorescein diacetate (DCFH-DA). After incubation for 30 min at 37 ºC 
in the dark under gentle agitation, various concentrations of rotenone, a widely used 
pharmacological inductor of ROS generation were added and fluorescence was 
measured at 5 min-intervals over a 30 min period in a Synergy Mx plate reader (BioTek 
Instruments). DCFH-DA fluorescence intensity was recorded after 30 min of rotenone 
treatment at 535 nm and after exciting the sample at 485 nm. Fluorescence intensity in 
each rotenone condition was calculated by subtracting the fluorescence emitted by 
untreated cells.  
To assess the ability of RhB-CeNPs as ROS biosensors we performed the same 
experiment as described previously, but without the addition of DCFH-DA. 
Fluorescence intensity of RhB was also measured at 5 min-intervals during a 30 min 
period after exciting the sample at 543 nm and recording the emission at 575, 600, 625, 
and 650 nm. The RhB fluorescence values shown are raw data after 30 min of rotenone 
treatment. 
 
CONCLUSION 
 
In the present study, ceria nanoparticles with rhodamine B groups covalently attached to 
their surface have been successfully prepared and characterized. These RhB-CeNPs 
exhibit antioxidant activity and sensor capacity against oxidant species both in solution 
and human cells submitted to oxidative stress. In addition, we have confirmed that RhB-
CeNPs can cross the cellular membrane and are remarkably biocompatible without 
increasing cell mortality. In these cells, RhB-CeNPs present a higher antioxidant 
capacity than the well-established CeNPs when there are harmful levels of ROS content, 
and exhibit a similar sensor capacity to the DCFH-DA probe. Thus, we present RhB-
CeNPs as a new class of nanomaterial with theranostic properties for oxidative stress. 
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